BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8512587)

  • 1. Activation of the jun-D gene during treatment of human myeloid leukemia cells with 1-beta-D-arabinofuranosylcytosine.
    Kharbanda S; Huberman E; Kufe D
    Biochem Pharmacol; 1993 May; 45(10):2055-61. PubMed ID: 8512587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
    Datta R; Kharbanda S; Kufe DW
    Mol Pharmacol; 1992 Jan; 41(1):64-8. PubMed ID: 1732724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
    Henschler R; Brennscheidt U; Mertelsmann R; Herrmann F
    Mol Pharmacol; 1991 Feb; 39(2):171-6. PubMed ID: 1996082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-jun gene expression in HL-60 leukemia cells by 1-beta-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism.
    Kharbanda S; Datta R; Kufe D
    Biochemistry; 1991 Aug; 30(32):7947-52. PubMed ID: 1907849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells.
    Kharbanda SM; Sherman ML; Kufe DW
    J Clin Invest; 1990 Nov; 86(5):1517-23. PubMed ID: 2122980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells.
    Datta R; Kharbanda S; Kufe D
    Mol Pharmacol; 1990 Oct; 38(4):435-9. PubMed ID: 2122229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
    Brach MA; Kharbanda SM; Herrmann F; Kufe DW
    Mol Pharmacol; 1992 Jan; 41(1):60-3. PubMed ID: 1732723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
    Kharbanda S; Emoto Y; Kisaki H; Saleem A; Kufe D
    Mol Pharmacol; 1994 Jul; 46(1):67-72. PubMed ID: 8058058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells.
    Brach MA; Herrmann F; Kufe DW
    Blood; 1992 Feb; 79(3):728-34. PubMed ID: 1310062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of c-fos gene expression by arabinofuranosylcytosine in human KG-1 leukemia cells.
    Kharbanda S; Datta R; Kufe D
    Cancer Commun; 1990; 2(12):409-14. PubMed ID: 2124813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the early growth response 1 gene and nuclear pp90rsk in human myeloid leukemia cells by 1-(beta-D-arabinofuranosyl)cytosine.
    Kharbanda S; Saleem A; Rubin E; Sukhatme V; Blenis J; Kufe D
    Biochemistry; 1993 Sep; 32(35):9137-42. PubMed ID: 7690249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-jun gene expression by cAMP in HL-60 myeloid leukemia cells.
    Nakamura T; Datta R; Sherman ML; Kufe D
    J Biol Chem; 1990 Dec; 265(35):22011-5. PubMed ID: 2174893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
    Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
    Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of jun-B expression by a cyclic AMP (cAMP)-dependent mechanism in human myeloid cells.
    Datta R; Nakamura T; Sherman ML; Kufe D
    Blood; 1991 Jul; 78(1):83-8. PubMed ID: 1648978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.
    Kuwakado K; Kubota M; Bessho R; Kataoka A; Usami I; Lin YW; Okuda A; Wakazono Y
    Leuk Res; 1995 Sep; 19(9):645-50. PubMed ID: 7564475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
    Rubin E; Kharbanda S; Gunji H; Kufe D
    Mol Pharmacol; 1991 Jun; 39(6):697-701. PubMed ID: 1904980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
    Barrett TJ; Vedeckis WV
    Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-beta-D-arabinofuranosylcytosine activates tyrosine phosphorylation of p34cdc2 and its association with the Src-like p56/p53lyn kinase in human myeloid leukemia cells.
    Yuan ZM; Kharbanda S; Kufe D
    Biochemistry; 1995 Jan; 34(3):1058-63. PubMed ID: 7530044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.